ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,870, issued on Nov. 25, was assigned to MEDIVIR AB (Huddinge, Sweden).
"Base-modified cytidine nucleotides for leukemia therapy" was invented by Pedro Pinho (Huddinge, Sweden), Bjorn Klasson (Huddinge, Sweden), John Ohd (Huddinge, Sweden) and Mark Albertella (Huddinge, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of the formula Iwherein X is a bond or -CH2, and pharmaceutically acceptable salts thereof are useful in the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, especially in patients presenting with cytarabine resistance and/or over 60 years of age."
The patent was filed on May 21, 2024, under Applic...